Fate Therapeutics Inc.

NASDAQ: FATE · Real-Time Price · USD
1.09
0.02 (1.87%)
At close: Aug 15, 2025, 3:59 PM
1.14
4.11%
After-hours: Aug 15, 2025, 07:57 PM EDT

Fate Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-171.52M -175.88M -186.26M -178.23M -175.72M -190.05M -160.93M -173.17M -211.56M -234.91M -281.72M -293.98M -253.72M -232.75M -212.15M -196.64M -212.02M -184.96M
Depreciation & Amortization
7.63M 9.92M 11.41M 11.48M 19.17M 18.91M 18.28M 18.24M 16.69M 15.19M 13.76M 11.12M 9.45M 7.65M 5.85M 4.5M 3.76M 3.34M
Stock-Based Compensation
35.42M 37.9M 41.5M 41.85M 40.19M 43.46M 43.46M 53.38M 62.74M 70.39M 78.73M 73.94M 68.01M 60.72M 54.36M 48.53M 42.83M 36.82M
Other Working Capital
2.48M -18K 816K 12.61M 4.76M 12.06M 15.47M -11.13M 204K -3.4M -16.92M 1.04M 108K 3.24M 11.13M 13.09M 1.92M -6.04M
Other Non-Cash Items
16.93M 12.67M 12.44M -12.78M -20.95M -20.71M -56.26M -54.09M -56.49M -52.21M -24.79M -20.76M -32.26M -24.76M -18.1M 11.15M 52.37M 108.53M
Deferred Income Tax
n/a n/a n/a 6.2M 2.94M n/a n/a -6.2M -2.94M n/a n/a 1.07M 2.44M 3.93M 5.07M 4.85M 3.79M 2.54M
Change in Working Capital
-4.08M -7.95M -1.96M -238K -6.19M 11.64M 23.18M -9.18M 3.77M -11.43M -34.71M -15.03M -15.88M -15.17M 2.1M 14.36M -1.33M -5.93M
Operating Cash Flow
-115.61M -123.33M -122.87M -131.71M -140.57M -136.75M -132.26M -171.01M -187.79M -212.46M -248.21M -243.11M -221.44M -200.39M -162.87M -113.24M -110.6M -39.65M
Capital Expenditures
-3.15M -1.84M -730K -813K -883K -3.03M -6.15M -12.65M -20.76M -28.69M -35.57M -47.26M -53.32M -56.81M -50.7M -34.61M -20.83M -7.84M
Cash Acquisitions
122K n/a n/a 73.28M 47.91M 12.55M n/a -133.07M -196.76M -161.39M -148.84M -89.05M n/a n/a n/a n/a n/a n/a
Purchase of Investments
-202.19M -280.04M -317.75M -329.71M -367.1M -330.69M -358.81M -415.95M -415.39M -387.08M -404.8M -471.14M -535.03M -570.42M -968.16M -979.72M -906.59M -807.25M
Sales Maturities Of Investments
315.76M 319.46M 330.7M 365.28M 402.08M 454.36M 477.63M 549.02M 612.15M 598.89M 607.11M 703.32M 770.85M 768.06M 694.84M 453M 233.98M 158.36M
Other Investing Acitivies
n/a n/a n/a -73.28M -47.91M -12.55M n/a 133.07M 196.76M 211.81M 202.32M 232.18M 235.81M 197.65M -273.32M -526.72M -672.6M -648.89M
Investing Cash Flow
110.54M 37.58M 12.22M 34.76M 34.1M 120.64M 112.67M 120.42M 176M 183.12M 166.75M 184.92M 182.5M 140.84M -324.02M -561.33M -693.43M -656.74M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a 666K n/a n/a n/a n/a n/a n/a n/a n/a -12.74M -12.74M -12.74M -12.74M n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
78.98M 79.6M 99.89M 22.23M 22.23M 20.35M 265K 1.78M 3.27M 6.62M 9.21M 11.11M 30.3M 30.61M 33.42M 34.91M 15.16M 14M
Financial Cash Flow
4.46M 4.4M 99.89M 96.58M 96.58M 95.37M 85K 1.78M 3.27M 6.62M 9.21M 11.11M 17.56M 17.88M 453.13M 454.62M 447.61M 719.44M
Net Cash Flow
-618K -81.35M -10.76M -375K -9.88M 79.25M -19.51M -48.81M -8.52M -22.72M -72.25M -47.09M -21.38M -41.67M -33.76M -219.95M -356.42M 23.05M
Free Cash Flow
-118.77M -125.17M -123.6M -132.53M -141.45M -139.78M -138.42M -183.66M -208.55M -241.15M -283.77M -290.37M -274.76M -257.19M -213.57M -147.85M -131.43M -47.49M